HOUSTON, May 8, 2014 /PRNewswire/ -- Solanbridge Group Inc
(OTC: SLNX) is pleased to announce the closing of the acquisition
of Tasty Greenz, LLC of Denver,
Colorado, a health product producer whose products are
derived from naturally occurring cannabinoids and, in particular,
cannabidiol (CBD). CBD is related to tetrahydrocannabinol (the
psychoactive constituent of the cannabis plant). CBD
possesses no psychoactive properties and therefore is a ready for
market marijuana based ingredient. Dr. Mark T. Cullen, chairman of the Scientific
Advisory Board of SLNX stated, "We are pleased to announce that
Tasty Greenz has agreed to join Solanbridge. We are looking forward
to working jointly with Tasty Greenz to further develop the medical
products that they have designed to utilize cannabidiol ("CBD"),
one of the many active ingredients derived from marijuana."
Cullen is a Yale University-trained
doctor and medical director, who had academic appointments at
Yale University and University of
Florida. Dr. Cullen has done collaborative work with the
World Health Organization (WHO), the Center for Disease Control
(CDC) and the National Institute of Health (NIH). He is an
entrepreneur who has developed start-up companies and has also
worked as the CEO of multiple companies both public and
private. He is an inventor who has created ultrasound
desulfurization and heavy oil upgrade technology. His work
has taken him throughout the world including Saudi Arabia, UAE, India, and South
America.
Charles R. Shirley, Chairman of
the Board and Managing Director of Solanbridge, stated that on
May 7, 2014, due to the commitment of
Solanbridge to the medical marijuana industry, the Company has
cancelled and retired another 500 million common stock shares of
SLNX. Those shares will be returned to the Company's Treasury
immediately. Concurrent with the announcement of the Company's
total share reduction, the Company emphasized that the long-term
goal of the Company is to reduce the number of common stock shares
by another 500 billion common stock shares over the next month—for
a total cancellation and retirement of 1.5 billion common stock
shares overall.
Solanbridge is also encouraged by the changing public opinion
landscape in certain U.S. jurisdictions and the potential for
legislative changes toward medical marijuana legalization in
Florida and Maryland, two jurisdictions where Solanbridge
has a physical presence.
The Company continues to pursue a commercial grower's license in
Province of Nova Scotia. Plans have been developed to hire a
full-time staff member to administer the application process,
acquire a building, equip the building with a state-of-the-art
security system, and build out all aspects of a commercial medical
marijuana grower's production facility. The MOU signed by the
Company on March 29, 2014 has been
extended for fourteen (14) more business days.
About Solanbridge Group Inc
Solanbridge Group Inc is based in Spring, Texas and is a diversified holding
company looking to expand into the medical marijuana industry by
developing a commercial grower's license in the Province of
Nova Scotia, Canada and developing
CBD-infused products in Colorado,
Nevada, and California through its subsidiary Tasty Greenz
LLC. Solanbridge's other subsidiary, David's Steak and Seafood, in
Melbourne Beach, Florida, is a
classic, upscale steak house, which presents polished dining in an
atmosphere of timeless elegance, offering guests the finest cuts of
choice USDA meats, fresh seafood and much more.
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended.
All forward-looking statements are inherently uncertain as they are
based on current expectations and assumptions concerning future
events or future performance of the company. Readers are cautioned
not to place undue reliance on these forward-looking statements,
which are only predictions and speak only as of the date hereof. In
evaluating such statements, prospective investors should review
carefully various risks and uncertainties identified in this
release and matters set in the company's SEC filings. These risks
and uncertainties could cause the company's actual results to
differ materially from those indicated in the forward-looking
statements.
SOURCE Solanbridge Group Inc